Genetic Polymorphisms Associated with Cerebral Palsy and Neurodevelopmental Delay

与脑瘫和神经发育迟缓相关的基因多态性

• 批准号: 8243557
• 负责人: Erin Clark
• 金额: $ 13.72万
• 依托单位: UNIVERSITY OF UTAH
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-04-19 至 2014-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8243557
• 关键词: Achievement; Award; Biological Assay; Blood Vessels; Brain Injuries; Cerebral Palsy; Cerebrum; Child; Clinical; Clinical Data; Clinical Investigator; Clinical Trials; Coagulation Process; Cohort Studies; Custom; Cytokine Network Pathway; DNA; DNA Library; Data; Development; Enrollment; Environment; Environmental Risk Factor; Ethics; Fellowship; Fetus; Funding; Future; Genes; Genetic; Genetic Polymorphism; Genetic Predisposition to Disease; Genetic Techniques; Genomics; Genotype; Goals; Gynecologic; Health Sciences; Housing; Human Genetics; Individual; Infant; Inflammation; Injury; Institution; Intervention Trial; Investigation; K-Series Research Career Programs; Leadership; Link; Mentored Patient-Oriented Research Career Development Award; Mentors; Motor Pathways; National Institute of Child Health and Human Development; Neonatal; Neurodevelopmental Disability; Oral; Outcome; Paper; Pathway interactions; Perinatal; Phenotype; Population Database; Predisposition; Premature Infant; Prematurity of fetus; Prevention strategy; Preventive Intervention; Qualifying; Regulation; Research; Research Design; Research Methodology; Research Training; Resources; Risk; Risk Factors; Sampling; Scientist; Single Nucleotide Polymorphism; Societies; Testing; Therapeutic Intervention; Time; Universities; Utah; Work; authority; base; career; career development; cohort; design; disability; experience; fetal; fetal medicine; follow-up; gene environment interaction; genetic analysis; genetic risk factor; legal implication; meetings; neurodevelopment; population based; programs; public health relevance; repository; response; skills; white matter

DESCRIPTION (provided by applicant): This career development award is designed to support my transition into an independent clinician-scientist dedicated to the study of genetic susceptibility to adverse neurodevelopmental outcomes. I completed a Maternal Fetal Medicine Fellowship at the University of Utah Health Sciences Center in June 2009. From July 2007 to present, I have been the recipient of the Eunice Kennedy Shriver NICHD Maternal-Fetal Medicine Units Network's Mentored Specialized Clinical Investigator Development Award (MSCIDA), which has provided support for initial training and research. This 2-year award qualifies as K-funding and will end in August 2009. I am fulfilling all of my funded training and research goals for the MSCIDA award. This research was presented at the 2009 Society of Maternal Fetal Medicine meeting (oral) and the 2009 Society for Gynecologic Investigation meeting (oral). This proposal outlines an extended training and research program that will provide me with a total of 5 years of protected, mentored time and will result in achievement of my goal of becoming an independent, extramurally funded and self-sustaining clinician-scientist. My specific career development aims are to 1) expand existing skills in study design, analysis, and interpretation of results, 2) develop additional skills in the acquisition, management, and analysis of genetic data, 3) develop additional skills in the design and implementation of clinical trials, 4) develop skills for leadership of a multi-disciplinary research team, and 5) understand the ethical and legal implications of research in clinical genetics and neurodevelopmental disability. My specific research aims are to 1) identify genetic polymorphisms that are associated with CP in preterm infants using a custom, multiplex SNP assay designed to assess ~1300 SNPs in inflammation, coagulation, vascular regulation and other genes, 2) identify genetic polymorphisms that are associated with neurodevelopmental delay in preterm infants using the same custom multiplex SNP assay, and 3) perform analyses to identify unique gene-gene and gene-environment interactions that contribute to susceptibility to adverse neurodevelopmental outcomes. This proposal represents a unique opportunity for correlation of genetic polymorphisms with well- characterized neurodevelopmental outcomes in a large cohort. It is also a unique opportunity to gain multi- disciplinary training and research experience to support my career goal of becoming a nationally-recognized expert in fetal genetic factors that contribute to adverse neurodevelopmental outcomes. PUBLIC HEALTH RELEVANCE: Although various perinatal complications increase the risk of an individual developing cerebral palsy or other forms of neurodevelopmental delay, the mechanisms by which at-risk individuals develop these complications are incompletely understood. This work will contribute to an increased understanding of the genetic risk factors predisposing a premature fetus to brain injury, and will therefore identify possible prevention strategies and may provide a basis for future prevention/ intervention trials. It will also enhance the career development of a promising young clinician-scientist within an environment with proven career-development capabilities. Dr. Clark has the enthusiastic support of her Division, Department and Institution (including at least 75% protected time and appropriate institutional funding).

描述（由申请人提供）：这个职业发展奖的目的是支持我过渡到一个独立的临床医生，科学家致力于研究遗传易感性不良神经发育结果。2009年6月，我完成了犹他州大学健康科学中心的孕产妇胎儿医学研究员。从2007年7月到现在，我一直是尤尼斯肯尼迪施莱佛NICHD母婴医学单位网络的指导专业临床研究者发展奖（MSCIDA）的获得者，该奖项为初始培训和研究提供了支持。这个为期两年的奖项有资格作为K资金，并将于2009年8月结束。我正在实现我所有的资助的培训和研究目标的MSCIDA奖。这项研究发表在2009年产妇胎儿医学学会会议（口头）和2009年妇科调查学会会议（口头）。 该提案概述了一个扩展的培训和研究计划，将为我提供总共5年的保护，指导时间，并将导致我成为一个独立的，校外资助和自我维持的临床科学家的目标的实现。我的具体职业发展目标是：1）扩展研究设计，分析和结果解释方面的现有技能，2）开发遗传数据获取，管理和分析方面的额外技能，3）开发临床试验设计和实施方面的额外技能，4）开发多学科研究团队的领导技能，5）了解临床遗传学和神经发育障碍研究的伦理和法律的含义。我的具体研究目标是1）使用定制的多重SNP测定来鉴定与早产儿CP相关的遗传多态性，该测定旨在评估炎症，凝血，血管调节和其他基因中的~1300个SNP，2）使用相同的定制多重SNP测定来鉴定与早产儿神经发育延迟相关的遗传多态性，和3）进行分析以鉴定导致对不良神经发育结果的易感性的独特基因-基因和基因-环境相互作用。 这一建议代表了一个独特的机会，在一个大的队列遗传多态性与良好表征的神经发育结果的相关性。这也是一个独特的机会，获得多学科的培训和研究经验，以支持我的职业目标，成为一个全国公认的专家在胎儿遗传因素，有助于不良神经发育结果。 公共卫生相关性：虽然各种围产期并发症增加了个体发生脑瘫或其他形式的神经发育迟缓的风险，但高危个体发生这些并发症的机制尚不完全清楚。这项工作将有助于增加对导致早产儿脑损伤的遗传风险因素的了解，因此将确定可能的预防策略，并可能为未来的预防/干预试验提供基础。它还将加强一个有前途的年轻临床医生，科学家的职业发展环境中具有公认的职业发展能力。克拉克有她的部门，部门和机构的热情支持（包括至少75%的保护时间和适当的机构资金）。

项目成果

Antenatal Magnesium Sulfate, Necrotizing Enterocolitis, and Death among Neonates < 28 Weeks Gestation.

• DOI: 10.1055/s-0036-1581059
• 发表时间: 2016-03
• 期刊: AJP reports
• 影响因子: 0.9
• 作者: Kamyar M;Clark EA;Yoder BA;Varner MW;Manuck TA
• 通讯作者: Manuck TA

Process Improvement for Interinstitutional Research Contracting.

机构间研究承包的流程改进。

• DOI: 10.1111/cts.12280
• 发表时间: 2015
• 期刊: Clinical and translational science
• 作者: Varner,Michael;Logan,Jennifer;Bjorklund,Todd;Whitfield,Jesse;Reed,Peggy;Lesher,Laurie;Sikalis,Amy;Brown,Brent;Drollinger,Sandy;Larrabee,Kristine;Thompson,Kristie;Clark,Erin;Workman,Michael;Boi,Luca
• 通讯作者: Boi,Luca

Risk Factors for Postcesarean Maternal Infection in a Trial of Extended-Spectrum Antibiotic Prophylaxis.

• DOI: 10.1097/aog.0000000000001899
• 发表时间: 2017-03
• 期刊: Obstetrics and gynecology
• 影响因子: 7.2
• 作者: Boggess KA;Tita A;Jauk V;Saade G;Longo S;Clark EAS;Esplin S;Cleary K;Wapner R;Letson K;Owens M;Blackwell S;Beamon C;Szychowski JM;Andrews W;Cesarean Section Optimal Antibiotic Prophylaxis Trial Consortium
• 通讯作者: Cesarean Section Optimal Antibiotic Prophylaxis Trial Consortium

Intrapartum magnesium sulfate and the potential for cardiopulmonary drug-drug interactions.

产时硫酸镁和心肺药物相互作用的可能性。

• DOI: 10.1097/ftd.0000000000000050
• 发表时间: 2014
• 期刊: Therapeutic drug monitoring
• 影响因子: 2.5
• 作者: Campbell,SarahC;Stockmann,Chris;Balch,Alfred;Clark,ErinAS;Kamyar,Manijeh;Varner,Michael;Korgenski,EKent;Bonkowsky,JoshuaL;Spigarelli,MichaelG;Sherwin,CatherineMT
• 通讯作者: Sherwin,CatherineMT